Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Elderly frailty may change how muscle relaxants work during surgery

NCT ID NCT07580144

First seen May 15, 2026 · Last updated Jun 23, 2026 · Updated 6 times

Summary

This study looks at whether sarcopenia (muscle loss) and frailty change how the muscle relaxant rocuronium works in older adults having planned surgery. Researchers will measure how fast the drug takes effect and how long it lasts in 100 patients aged 65 and older. The goal is to gather information that could help doctors give safer anesthesia doses to this group.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FRAILTY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Betul Kozanhan

    RECRUITING

    Konya, 42005, Turkey (Türkiye)

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

rocuronium

What this could lead to

If successful, this could help anesthesiologists tailor rocuronium doses for elderly patients with sarcopenia or frailty, potentially reducing risks during surgery.

What could go wrong

This is an observational study, not a treatment trial. It only measures effects without testing a new drug or intervention, so direct patient benefits are uncertain.

Conditions

The condition(s) this trial relates to.

Frailty Sarcopenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.